Richard James Hill serves as Executive at Biota Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Richard James Hill has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 15, 2014 involved receiving (via award) 7,500 shares valued at $0.
Richard James Hill currently holds 7,500 shares of Biota Pharmaceuticals, Inc. (BOTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard James Hill has been a net neutral trader of BOTA stock. They have purchased $0 and sold $0 worth of shares.
Richard James Hill's most recent insider trade was on May 15, 2014, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |